Cargando…
Unravelling the therapeutic potential of IL-33 for atrophic AMD
Age-related macular degeneration (AMD), a degenerative disease affecting the retinal pigment epithelium (RPE) and photoreceptors in the macula, is the leading cause of central blindness in the elderly. AMD progresses to advanced stages of the disease, atrophic AMD (aAMD), or in 15% of cases “wet” or...
Autores principales: | Clare, Alison J., Liu, Jian, Copland, David A., Theodoropoulou, Sofia, Dick, Andrew D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807696/ https://www.ncbi.nlm.nih.gov/pubmed/34531552 http://dx.doi.org/10.1038/s41433-021-01725-5 |
Ejemplares similares
-
Treatment with interleukin‐33 is non‐toxic and protects retinal pigment epithelium in an ageing model of outer retinal degeneration
por: Clare, Alison J., et al.
Publicado: (2020) -
Interleukin‐33 regulates tissue remodelling and inhibits angiogenesis in the eye
por: Theodoropoulou, Sofia, et al.
Publicado: (2016) -
Restoring retinal neurovascular health via substance P
por: Ou, Kepeng, et al.
Publicado: (2019) -
Treatment of diabetic retinopathy through neuropeptide Y‐mediated enhancement of neurovascular microenvironment
por: Ou, Kepeng, et al.
Publicado: (2020) -
Corrigendum to “Restoring retinal neurovascular health via substance P” [Exp. Cell Res. (2019)]
por: Ou, Kepeng, et al.
Publicado: (2019)